141 related articles for article (PubMed ID: 5755673)
1. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
Vannas S; Esilä R; Tuovinen E
Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
[No Abstract] [Full Text] [Related]
2. [Action mechanism and clinical success of Regelan (Clofibrate)].
Fitzgerald JD
Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
[No Abstract] [Full Text] [Related]
3. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
[No Abstract] [Full Text] [Related]
4. A three-year trial of atromid therapy in exudative diabetic retinopathy.
Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
[No Abstract] [Full Text] [Related]
5. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
[No Abstract] [Full Text] [Related]
6. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
Engström J
Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
[No Abstract] [Full Text] [Related]
7. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
Cullen JF; Ireland JT; Oliver MF
Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
[No Abstract] [Full Text] [Related]
8. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
Duncan GG; Elliott FA; Duncan TG; Schatanoff J
Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
[No Abstract] [Full Text] [Related]
9. Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.
Danowski TS; Novak JF; Saul RW; Vester JW; Moses C
Clin Pharmacol Ther; 1966; 7(5):631-8. PubMed ID: 5957168
[No Abstract] [Full Text] [Related]
10. Trial of "Atheran" and "Atromid-S" in atherosclerosis.
Barnett AJ; Carson V
Med J Aust; 1966 Jun; 1(23):965-70. PubMed ID: 5939995
[No Abstract] [Full Text] [Related]
11. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
[No Abstract] [Full Text] [Related]
12. REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).
BEST MM; DUNCAN CH
Am J Cardiol; 1965 Feb; 15():230-3. PubMed ID: 14254816
[No Abstract] [Full Text] [Related]
13. Atromid-S for the reduction of plasma lipids.
Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
[No Abstract] [Full Text] [Related]
14. [Clinical-experimental studies on lipid metabolism using Regelan].
Hammerl H
Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
[No Abstract] [Full Text] [Related]
15. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
Schatz IJ
Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
[No Abstract] [Full Text] [Related]
16. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
Cloarec M; Cottet J; Etienne J; Loeper J
Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
[No Abstract] [Full Text] [Related]
17. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144
[No Abstract] [Full Text] [Related]
18. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
Warembourg H; Jaillard J
Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
[No Abstract] [Full Text] [Related]
19. [CPIB: a hypolipidemic agent. Study of 20 patients].
Verdy M
Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817
[No Abstract] [Full Text] [Related]
20. Ethyl chlorophenoxyisobutyrate (CPIB) effects in juvenile-onset diabetes mellitus.
Danowski TS; Cohn RE; Limaye NR; Novak JF; Saul R; Sunder JH; Moses C
Clin Pharmacol Ther; 1965; 6(6):716-30. PubMed ID: 5321221
[No Abstract] [Full Text] [Related]
[Next] [New Search]